Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00513097 · ClinicalTrials.gov registry record · Phase 1

Curbing Tobacco Use in Suburban and Rural Schools

A Phase 1 study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
Phase 1
Development phase
1,289
Enrollment target

NCT00513097: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.

NCT00513097 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,289 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00513097, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
Phase 1
Development phase
1,289 participants
Enrollment target

Study Summary

Primary, secondary, and tertiary specific aims are to answer the following questions about interactive, Internet-based tobacco control intervention directed towards 10th-graders: 1. Smoking Prevention (primary): Does the intervention result in a lower incidence of smoking initiation compared to standard care? 2. Smoking Cessation (primary): Does the intervention result in higher rates of smoking cessation compared to standard care? 3. Reduction of Spit Tobacco Use (secondary): Does the intervention have an impact on spit tobacco use compared to standard care? 4. Stages of Change (tertiary): Does the intervention have an impact on progression through the stages of smoking and spit tobacco acquisition and cessation compared to standard care? 5. Mediating Variables (tertiary): How are mediating variables associated with tobacco-use onset and cessation? 6. Testing Predictors: Investigate established and recently elucidated predictors of susceptibility to smoking at baseline and 12-month follow-up. 7. Develop/Validate Spit Tobacco Measures: Investigate predictors of susceptibility of spit tobacco use at baseline and 12-month follow-up 8. Testing Measures Across Race/Ethnicity: Explore predictors of susceptibility to smoking at baseline and 12-month follow-up to determine whether predictors differ among White, African-American, and Hispanic students.

Interventions

  • BEHAVIORAL Focus Group
  • BEHAVIORAL Survey
  • BEHAVIORAL Smoking Prevention Program

Trial Details

FieldValue
Enrollment Target 1,289 participants
Start Date 2006-07-25
Est. Completion 2017-10-18
Phase Phase 1

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00513097

The ClinicalTrials.gov registry entry for NCT00513097 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1,289 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Focus Group is the first listed.

NCT00513097 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00513097 about?

NCT00513097 is a clinical study titled "Curbing Tobacco Use in Suburban and Rural Schools". Primary, secondary, and tertiary specific aims are to answer the following questions about interactive, Internet-based tobacco control intervention directed towards 10th-graders: 1. Smoking Prevention (primary): Does the intervention result in a lower incidence of smoking initiation compared to sta...

What is the current status of trial NCT00513097?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 1,289 participants. The study started on 2006-07-25. Estimated completion is 2017-10-18.

What interventions are being tested in trial NCT00513097?

The interventions under investigation include: Focus Group (BEHAVIORAL), Survey (BEHAVIORAL), Smoking Prevention Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00513097?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.